Kaihua Gong

Kaihua Gong

Auto-generated profile, based on publicly available information

Kaihua Gong

School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang, Liaoning 110016, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2023 in Chemical Engineering Journal
Verified
Journal Article
Closed access
YCYu Cai
Yu Cai
CLChao Liu
Chao Liu
KGKaihua Gong
Kaihua Gong
HLHui Li
Hui Li
HSHaoyuan Song
Haoyuan Song
LFLiang Fang
Liang Fang

21 July 2021 in Physical Chemistry Chemical Physics
Verified
Journal Article
Closed access
PDF file
YYYe Yang
Ye Yang
BHBaichun Hu
Baichun Hu
YYYi Yang
Yi Yang
KGKaihua Gong
Kaihua Gong
HWHuibin Wang
Huibin Wang
JWJian Wang
Jian Wang
The rational design of selective histone deacetylase 2 (HDAC2) inhibitors is beneficial for the therapeutic treatment of liver cancer, though HDAC2 is highly homologous to HDAC8, which may lead to undesired side effects due to the pan-inhibition towards HDAC2 and HDAC8. To clarify the structural basis of selective inhibition towards HDAC2 over HDAC8, we utilized multiple in silico strategies, including sequence alignment, structural comparison, molecular docking, molecular dynamics simulations, free energy calculations, alanine scanning mutagenesis, pharmacophore modeling, protein contacts atlas analysis and QM/MM calculations to study the binding patterns of HDAC2/8 selective inhibitors. Through the whole process described above, it is found that although HDAC2 has conserved GLY154 and PHE210 that also exist within HDAC8, namely GLY151 and PHE208, the two isoforms exhibit diverse binding modes towards their inhibitors. Typically, HDAC2 inhibitors interact with the Zn2+ ions through the core chelate group, while HDAC8 inhibitors adopt a bent conformation within the HDAC8 pocket that inclines to be in contact with the Zn2+ ions through the terminal hydroxamic acid group. In summary, our data comprehensively elucidate the selectivity mechanism towards HDAC2 over HDAC8, which would guide the rational design of selective HDAC2 inhibitors for liver cancer treatment.

28 October 2024 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
PSPeng Sun
Peng Sun
HLHui Li
Hui Li
KGKaihua Gong
Kaihua Gong
YZYang Zhang
Yang Zhang
YCYu Cai
Yu Cai
LFLiang Fang
Liang Fang

29 October 2024 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
YPYu Pang
Yu Pang
WJWenxuan Jia
Wenxuan Jia
LWLiuyang Wang
Liuyang Wang
YZYang Zhang
Yang Zhang
KGKaihua Gong
Kaihua Gong
LFLiang Fang
Liang Fang